Cheng Zhongshan, Vermeulen Michael, Rollins-Green Micheal, DeVeale Brian, Babak Tomas
Department of Biology, Queen's University, Kingston, ON K7L 3N6, Canada.
The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Center for Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
iScience. 2021 Feb 4;24(3):102144. doi: 10.1016/j.isci.2021.102144. eCollection 2021 Mar 19.
Despite the recent availability of complete genome sequences of tumors from thousands of patients, isolating disease-causing (driver) non-coding mutations from the plethora of somatic variants remains challenging, and only a handful of validated examples exist. By integrating whole-genome sequencing, genetic data, and allele-specific gene expression from TCGA, we identified 320 somatic non-coding mutations that affect gene expression in (FDR<0.25). These mutations cluster into 47 cis-regulatory elements that modulate expression of their subject genes through diverse molecular mechanisms. We further show that these mutations have hallmark features of non-coding drivers; namely, that they preferentially disrupt transcription factor binding motifs, are associated with a selective advantage, increased oncogene expression and decreased tumor suppressor expression.
尽管最近已有数千名患者肿瘤的全基因组序列,但从大量体细胞变异中分离出致病(驱动)非编码突变仍然具有挑战性,目前仅有少数经过验证的实例。通过整合来自癌症基因组图谱(TCGA)的全基因组测序、遗传数据和等位基因特异性基因表达数据,我们鉴定出320个体细胞非编码突变,这些突变影响基因表达(错误发现率<0.25)。这些突变聚集在47个顺式调控元件中,通过多种分子机制调节其相关基因的表达。我们进一步表明,这些突变具有非编码驱动因子的标志性特征;即它们优先破坏转录因子结合基序,与选择性优势、癌基因表达增加和肿瘤抑制基因表达降低相关。